430 related articles for article (PubMed ID: 37408838)
21. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.
Fukui H
Gut Liver; 2021 Sep; 15(5):666-676. PubMed ID: 33071239
[TBL] [Abstract][Full Text] [Related]
22. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
[TBL] [Abstract][Full Text] [Related]
24. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
[TBL] [Abstract][Full Text] [Related]
25. Effect of intestinal microbiota on liver disease and its related future prospection: From the perspective of intestinal barrier damage and microbial metabolites.
Jiang N; Xiao Y; Yuan K; Wang Z
J Gastroenterol Hepatol; 2023 Jul; 38(7):1056-1071. PubMed ID: 36662612
[TBL] [Abstract][Full Text] [Related]
26. Gut Barrier and Microbiota in Cirrhosis.
Philips CA; Augustine P
J Clin Exp Hepatol; 2022; 12(2):625-638. PubMed ID: 35535069
[TBL] [Abstract][Full Text] [Related]
27. Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis.
Fan Y; Li Y; Chu Y; Liu J; Cui L; Zhang D
Front Immunol; 2021; 12():608498. PubMed ID: 33708204
[TBL] [Abstract][Full Text] [Related]
28. Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study.
Saha P; Upright M; Bose D; Roy S; Trivedi A; More M; Scott GI; Brooks BW; Chatterjee S
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548732
[TBL] [Abstract][Full Text] [Related]
29. The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
Lee NY; Suk KT
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379148
[TBL] [Abstract][Full Text] [Related]
30. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
31. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
[TBL] [Abstract][Full Text] [Related]
32. The gut microbiota-bile acid axis: A potential therapeutic target for liver fibrosis.
Zhang YL; Li ZJ; Gou HZ; Song XJ; Zhang L
Front Cell Infect Microbiol; 2022; 12():945368. PubMed ID: 36189347
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
Shu W; Shanjian C; Jinpiao L; Qishui O
Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
[TBL] [Abstract][Full Text] [Related]
34. The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC.
Song Q; Zhang X
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327326
[TBL] [Abstract][Full Text] [Related]
35. The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections.
Ancona G; Alagna L; Lombardi A; Palomba E; Castelli V; Renisi G; Dondossola D; Iavarone M; Muscatello A; Gori A; Bandera A
Infect Immun; 2021 Oct; 89(11):e0037621. PubMed ID: 34460287
[TBL] [Abstract][Full Text] [Related]
36. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature.
Giuffrè M; Campigotto M; Campisciano G; Comar M; Crocè LS
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G889-G906. PubMed ID: 32146836
[TBL] [Abstract][Full Text] [Related]
37. Host-microbiome interactions: Gut-Liver axis and its connection with other organs.
Anand S; Mande SS
NPJ Biofilms Microbiomes; 2022 Nov; 8(1):89. PubMed ID: 36319663
[TBL] [Abstract][Full Text] [Related]
38. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
39. The Link between Gut Microbiota and Hepatic Encephalopathy.
Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota influence tumor development and Alter interactions with the human immune system.
Ge Y; Wang X; Guo Y; Yan J; Abuduwaili A; Aximujiang K; Yan J; Wu M
J Exp Clin Cancer Res; 2021 Jan; 40(1):42. PubMed ID: 33494784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
